Synergy is documented in vitro with low-dose recombinant...

Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells

Benjamin Bonavida, Toshiharu Tsuchitani, Jacob Zighelboim, Jonathan S. Berek
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
38
Year:
1990
Language:
english
DOI:
10.1016/0090-8258(90)90068-v
File:
PDF, 624 KB
english, 1990
Conversion to is in progress
Conversion to is failed